Celldex Therapeutics | CLDX - Eps Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q1 Mar/2026 -1.19 -0.71 Apr/30 2026
FY2025Q4 Dec/2025 -1.22 -1 -0.71 Feb/25 2026
FY2025Q3 Sep/2025 -1.01 -0.9 -0.64 Nov/10 2025
FY2025Q2 Jun/2025 -0.85 -0.80 -0.54 Aug/07 2025
FY2025Q1 Mar/2025 -0.71 -0.76 -0.56 May/05 2025




Eps Cambiamento Data
AbbVie USD 2.71 0.85 2025-12
Agenus USD -0.3 0.84 2025-12
Amgen USD 5.29 0.35 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Celldex Therapeutics USD -1.22 0.21 2025-12
Glaxosmithkline GBP 0.21 0.51 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Northwest Biotherapeutics USD -0.02 0 2024-09
Pfizer USD 0.66 0.21 2025-12
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
Roche Holding CHF 8.37 2.95 2025-12